Table 3. Values of proADM and proANP in the presence of complications after surgery.
Variables | ProADM (nmol/L) | ProANP (pmol/L) | |
---|---|---|---|
Pulmonary hypertension | Yes (n = 3) | 0.46 (0.44–0.51) | 80.2 (66.2-202-9) |
No (n = 110) | 0.47 (0.35–0.65) | 116.3 (73.7–229.3) | |
p | 0.926 | 0.605 | |
Arrhythmia | Yes (n = 5) | 0.63 (0.42–1.53) | 343 (157.6–667.9) |
No (n = 108) | 0.46 (0.35–0.64) | 110.4 (73.4–222) | |
p | 0.214 | 0.065 | |
Low cardiac output syndrome | Yes (n = 5) | 0.65 (0.46–0.66) | 482.7 (155.4–782.3) |
No (n = 108) | 0.46 (0.35–0.64) | 110.4 (73.5–226.4) | |
p | 0.494 | 0.102 | |
Neurological disability | Yes (n = 2) | 2.39 (0.98–3.80) | 2052 (1938–2166) |
No (n = 111) | 0.46 (0.35–0.64) | 112 (73.5–226.4) | |
p | 0.013 | 0.001 | |
Renal replacement therapy | Yes (n = 2) | 2.39 (0.98–3.80) | 2052 (1938–2166) |
No (n = 111) | 0.46 (0.35–0.64) | 112 (73.5–226.4) | |
p | 0.013 | 0.001 | |
Extracorporeal circulatory support | Yes (n = 1) | 0.98 | 1938 |
No (n = 112) | 0.46 (0.35–0.64) | 113.7 (73.5–228.5) | |
p | 0.230 | 0.053 | |
Major complication | Yes (n = 4) | 0.77 (0.34–3.09) | 1140 (135.3–2109) |
No (n = 109) | 0.46 (0.35–0.64) | 112 (73.5–226.4) | |
p | 0.320 | 0.074 | |
Prolonged length of stay | Yes (n = 33) | 0.62 (0.47–0.75) | 191 (117.1–342.8) |
No (n = 80) | 0.42 (0.33–0.57) | 96.4 (66.7–177.0) | |
p | 0.001 | 0.001 | |
Mortality in the pediatric intensive care unit | Yes (n = 1) | 0.98 | 1938 |
No (n = 112) | 0.46 (0.35–0.64) | 113.7 (73.5–228.5) | |
p | 0.230 | 0.053 |
Values are expressed as median (IQR) and compared using the Mann-Whitney U test.